MAGEA3
MAGEA3 (MAGE family member A3, also known as MAGE3, HYPD, HIP8 and CT1.3) is a member of the MAGEA family. It activates RING-type E3 ubiquitin ligases, acts as a repressor of autophagy, and is an antigen recognised on melanoma by autologous cytolytic T-lymphocytes. Browse Assay Genie's current range of MAGEA3 research reagents below, or read on for the biology behind the target.
MAGEA3 is an activator of the ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases, and it acts as a repressor of autophagy. It may enhance the ubiquitin ligase activity of TRIM28 and stimulate ubiquitination of p53/TP53 by TRIM28. The proposed mechanism is recruitment and/or stabilisation of the Ubl-conjugating enzyme (E2) at the E3:substrate complex.
The MAGEA3 gene belongs to the MAGEA gene family, whose members encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes vary considerably, which suggests that the family allows the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at Xq28. The protein is listed by UniProt as melanoma-associated antigen 3, and the gene was previously named melanoma antigen family A3.
MAGEA3 may play a role in embryonal development and in tumour transformation or aspects of tumour progression. In vitro, it promotes cell viability in melanoma cell lines. It is also an antigen recognised on a melanoma by autologous cytolytic T-lymphocytes, which is the basis of its name. More broadly, MAGEA genes have been implicated in some hereditary disorders, such as dyskeratosis congenita. Researchers studying MAGEA3 often compare it with other MAGEA members such as MAGEA1, MAGEA2 and MAGEA4.
MAGEA3 is an antigen recognised on melanoma by autologous cytolytic T-lymphocytes, making it a reference point for studies of tumour antigen recognition.
In vitro, MAGEA3 promotes cell viability in melanoma cell lines, so it is studied in relation to tumour cell survival.
MAGEA3 may enhance TRIM28 ubiquitin ligase activity and p53 ubiquitination, supporting work on E3:E2 recruitment and substrate control.
MAGEA3 acts as a repressor of autophagy, linking this MAGE family protein to the regulation of autophagic pathways.
MAGEA3 activates RING-type zinc finger E3 ubiquitin ligases and acts as a repressor of autophagy. It may enhance TRIM28 activity and p53 ubiquitination, and is proposed to recruit or stabilise the E2 enzyme at the E3:substrate complex. In vitro it promotes viability of melanoma cell lines.
MAGEA3 is also known as MAGE3, HYPD, HIP8, MGC14613 and CT1.3. The HGNC name is MAGE family member A3, the UniProt protein name is melanoma-associated antigen 3, and the previous gene name was melanoma antigen family A3.
MAGEA3 may play a role in tumour transformation or progression and is a melanoma antigen recognised by cytolytic T-lymphocytes. The MAGEA family has been implicated in hereditary disorders such as dyskeratosis congenita. Mouse and rat orthologs are not given in the source data.
Other MAGEA family members and cancer-testis antigens studied alongside MAGEA3 in tumour biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P43357; product specifications from Assay Genie datasheets.